Literature DB >> 8454289

Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.

A Lindblom1, L Skoog, T I Andersen, S Rotstein, M Nordenskjöld, C Larsson.   

Abstract

Two genes predisposing females to autosomal dominant breast cancer are located on chromosome 17. Mutations in the p53-gene on the short arm have been shown to predispose females to early onset breast cancer in families with the rare Li-Fraumeni syndrome. Another locus on 17q (BRCA1), was found to be linked to the disease in a subset of families with breast cancer. In order to determine the involvement of tumour suppressor genes at these loci in tumour development, we studied allele losses for markers on chromosome 17 in 78 familial breast carcinomas. The analysis used six polymorphic DNA markers, three on each arm. We found support for at least four separate regions displaying allele losses on chromosome 17: the p53-region, the distal part of 17p, the BRCA1 region and the distal part of 17q. The frequency of allele losses on distal 17p (16%) is low in these familial tumours compared with the previously reported incidence in sporadic tumours (> 50%), whereas the frequency of losses at the p53 locus and on 17q was similar to sporadic tumours (5%-40%). These data suggest that several regions on chromosomal 17 can harbour tumour suppressor genes involved in tumour development of familial breast cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454289     DOI: 10.1007/bf00230213

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  38 in total

1.  The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII.

Authors:  L Varesco; M A Caligo; P Simi; D M Black; V Nardini; L Casarino; M Rocchi; G Ferrara; E Solomon; G Bevilacqua
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

2.  Retinoblastoma: a prototypic hereditary neoplasm.

Authors:  A G Knudson
Journal:  Semin Oncol       Date:  1978-03       Impact factor: 4.929

3.  Somatic mutations in the neurofibromatosis 1 gene in human tumors.

Authors:  Y Li; G Bollag; R Clark; J Stevens; L Conroy; D Fults; K Ward; E Friedman; W Samowitz; M Robertson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

4.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

5.  Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.

Authors:  W Xu; L M Mulligan; M A Ponder; L Liu; B A Smith; C G Mathew; B A Ponder
Journal:  Genes Chromosomes Cancer       Date:  1992-06       Impact factor: 5.006

6.  Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.

Authors:  T I Andersen; A Gaustad; L Ottestad; G W Farrants; J M Nesland; K M Tveit; A L Børresen
Journal:  Genes Chromosomes Cancer       Date:  1992-03       Impact factor: 5.006

Review 7.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

Review 8.  Epidemiology and risk factors.

Authors:  H T Lynch; P Watson; J F Lynch
Journal:  Clin Obstet Gynecol       Date:  1989-12       Impact factor: 2.190

9.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

10.  Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

Authors:  C S Cropp; R Lidereau; G Campbell; M H Champene; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

View more
  9 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

Review 2.  Tumor suppressor genes and their roles in breast cancer.

Authors:  L A Cox; G Chen; E Y Lee
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.

Authors:  A E Karlbom; C D James; J Boethius; W K Cavenee; V P Collins; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

4.  Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome.

Authors:  M Zelada-Hedman; M Torroella; R Mesquita; M Nordenskjöld; L Skoog; A Lindblom
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

5.  Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.

Authors:  G Meroni; A Reymond; M Alcalay; G Borsani; A Tanigami; R Tonlorenzi; C Lo Nigro; S Messali; M Zollo; D H Ledbetter; R Brent; A Ballabio; R Carrozzo
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

Authors:  J Papp; B Csokay; P Bosze; Z Zalay; J Toth; B Ponder; E Olah
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

7.  Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.

Authors:  D S Liscia; R Morizio; T Venesio; C Palenzona; M Donadio; R Callahan
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.

Authors:  M Zelada-Hedman; A L Børresen-Dale; A Claro; J Chen; L Skoog; A Lindblom
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region.

Authors:  B Leggett; J Young; R Buttenshaw; L Thomas; B Young; G Chenevix-Trench; J Searle; M Ward
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.